Guardant Stock Today

GH -  USA Stock  

USD 112.22  2.56  2.33%

Guardant Health is trading at 112.22 as of the 29th of July 2021. This is a 2.33 percent increase since the beginning of the trading day. The stock's open price was 109.66. Guardant Health has about a 42 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Guardant Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of January 2021 and ending today, the 29th of July 2021. Click here to learn more.
 Market Performance
0 of 100
  Odds Of Distress
Less than 42

Guardant Health Stock Profile

The upcoming quarterly report is expected on the 5th of August 2021. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. Guardant Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 864 people. more on Guardant Health
Guardant Health generates negative expected return over the last 90 days
The company generated the yearly revenue of 297.88 M. Annual Net Loss to common stockholders was (335.71 M) with gross profit of 194.19 M.
Guardant Health reports about 1.94 B in cash with (106.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.19.
Guardant Health has a frail financial position based on the latest SEC disclosures
Over 92.0% of the company shares are owned by institutional investors
Latest headline from www.equities.com: Guardant Health Inc falls 6.12 percent for July 26 - Equities.com
Guardant Health Fama & French Healthcare
Healthcare
Fama & French Classification
Guardant Health SEC Filings
Guardant Health SEC Filings Security & Exchange Commission EDGAR Reports
Legal NameGuardant Health
CEO, DirectorHelmy Eltoukhy  (View All)
Thematic Classification
Currently Active Investing Idea (view all)
  Healthcare
Average Analyst Recommendation
Analysts covering Guardant Health report their recommendations after researching Guardant Health's financial statements, talking to executives and customers, or listening in on Guardant Health's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Guardant Health. The Guardant consensus assessment is calculated by taking the average forecast from all of the analysts covering Guardant Health.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Guardant Health based on its profitability, leverage, liquidity, source of funds, and operating efficiency. it is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Guardant Health financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 3 - FrailDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares79.6 M97.5 M
Significantly Down
Increasing
Slightly volatile
Weighted Average Shares Diluted79.6 M97.5 M
Significantly Down
Increasing
Slightly volatile
Total Assets2.5 B2.3 B
Significantly Up
Increasing
Slightly volatile
Total Liabilities988.5 M916.2 M
Significantly Up
Increasing
Slightly volatile
Current AssetsB1.9 B
Significantly Up
Increasing
Slightly volatile
Current Liabilities60.7 M66.8 M
Moderately Down
Increasing
Slightly volatile
Total Debt914.8 M847.9 M
Significantly Up
Increasing
Slightly volatile
Gross Margin0.630.677
Significantly Down
Increasing
Slightly volatile
Asset Turnover0.230.199
Fairly Up
Increasing
Very volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Guardant Health's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Cautious HoldUndervalued
Financial Strength
Guardant Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Guardant Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Guardant Health's financial leverage. It provides some insight into what part of Guardant Health's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Guardant Health's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Guardant Health deploys its capital and how much of that capital is borrowed.
Liquidity
Guardant Health cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company reports 1.35 B of total liabilities with total debt to equity ratio (D/E) of 1.49, which is normal for its line of buisiness. Guardant Health has a current ratio of 20.86, indicating that it is in good position to pay out its debt commitments in time.

Operating Cash Flow

(112.13 Million)Share
Guardant Health (GH) is traded on NASDAQ Exchange in USA. It is located in 505 Penobscot Drive and employs 864 people. Guardant Health is listed under Healthcare category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with market capitalization of 12.04 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Guardant Health's market, we take the total number of its shares issued and multiply it by Guardant Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Guardant Health is active under Healthcare sector as part of Diagnostics & Research industry. The entity has 101.12 M outstanding shares of which 3.98 M shares are currently sold short in the market by investors with about 3.88 days to cover all shorted shares. Guardant Health reports about 1.94 B in cash with (106.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.19.
Check Guardant Health Probability Of Bankruptcy
Ownership
Guardant Health has a total of one hundred one million one hundred twenty thousand outstanding shares. The majority of Guardant Health outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Guardant Health to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Guardant Health. Please pay attention to any change in the institutional holdings of Guardant Health as this could imply that something significant has changed or about to change at the company. Please note that no matter how much assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Guardant Ownership Details

Guardant Stock Price Odds Analysis

What are Guardant Health's target price odds to finish over the current price? In reference to a normal probability distribution, the odds of Guardant Health jumping above the current price in 90 days from now is about 82.09%. The Guardant Health probability density function shows the probability of Guardant Health stock to fall within a particular range of prices over 90 days. Allowing for the 90-day total investment horizon Guardant Health has a beta of 0.1069. This usually indicates as returns on the market go up, Guardant Health average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Guardant Health will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Guardant Health is significantly underperforming DOW.
 Odds Down 112.22HorizonTargetOdds Up 112.22 
17.82%90 days
 112.22 
82.09%
Based on a normal probability distribution, the odds of Guardant Health to move above the current price in 90 days from now is about 82.09 (This Guardant Health probability density function shows the probability of Guardant Stock to fall within a particular range of prices over 90 days) .

Guardant Health Historical Income Statement

Guardant Health Income Statement is one of the three primary financial statements used for reporting Guardant's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Guardant Health revenue and expense. Guardant Health Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Guardant Health Research and Development Expense is most likely to increase significantly in the upcoming years. The last year's value of Research and Development Expense was reported at 149.86 Million. The current Selling General and Administrative Expense is estimated to increase to about 322.9 M, while Consolidated Income is projected to decrease to (252.8 M). View More Fundamentals

Guardant Stock Against Markets

Picking the right benchmark for Guardant Health stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Guardant Health stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Guardant Health is critical whether you are bullish or bearish towards Guardant Health at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Guardant Health without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bond Directory Now

   

Bond Directory

Find actively traded corporate debentures issued by US companies
All  Next Launch Module

Guardant Health Corporate Directors

Guardant Health corporate directors refer to members of a Guardant Health board of directors. The board of directors generally takes responsibility for the Guardant Health's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Guardant Health's board members must vote for the resolution. The Guardant Health board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Dipchand Nishar - Independent DirectorProfile
Ian Clark - Lead Independent DirectorProfile
Bahija Jallal - DirectorProfile
Stanley Meresman - Independent DirectorProfile
Please check Risk vs Return Analysis. Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Guardant Stock analysis

When running Guardant Health price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Guardant Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.